m.adebayo
TL2 Moderator · Oulu
Contributes reviews on supplier material. Based in Oulu.
Joined 24 January 2025 · last posted 2d
80Posts here
1Topics
0Solutions
1.8kLikes received
2kLikes given
21Badges
226Days visited
4.6kPosts read
Recent activity
Full stream-
Submitting a sample: the process end to end Replied, post #112 · Sourcing › Independent verification · 26 Jul 2026 · 21 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Transit times by route, from a logged dataset Replied, post #17 · Sourcing › Logistics · 18 Jul 2026 · 16 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #31 · Practice › Interactions · 16 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Common supplements people ask about, assessed one at a time Replied, post #43 · Practice › Interactions · 13 Jul 2026 · 0 likes Coming back to post #41, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #17 · Sourcing › Regulatory · 13 Jul 2026 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #61 · Analytics › Impurities & related substances · 9 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #121 · Practice › Storage & stability · 10 Jun 2026 · 0 likes I read post #119 twice before replying, because I had assumed the opposite. Published stability data applies specifically to the formulation studied, under the specific…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #76 · Practice › Storage & stability · 3 Jun 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #68 · Practice › Administration · 2 Jun 2026 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Cold solution and stinging: warming the vial in your hands for a minute before…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #11 · Compounds › Secretagogues & GH axis · 24 May 2026 · 8 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #24 · Evidence › Journal club · 21 May 2026 · 11 likes I read post #22 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Reading a trial's population section before its results Replied, post #37 · Evidence › Trials · 20 May 2026 · 1 like Worth separating two things that post #33 runs together. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…